MILLS REGAN (President, Product Test) sold 6.2% of their position (788.00 shares) of TERADYNE, INC on the open market
Open‑market sale worth $262.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2026ACC: 0000904454-26-000130
Officer· President, Product Test
Since Feb 2026
-788.00
Net shares
Net seller
$262.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
788.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−788.00
Price / share
$332.87
Trade value
$262.30K
% of position
6.2%
2/25/2026
12.68K→11.89K
Total
Net shares
−788.00
Net value
-$262.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2026 | S · Sale | −788.00 | $332.87 | $262.30K | 6.2% | 12.68K | 11.89K |
| Total | −788.00 | -$262.30K | ||||||
Derivative Transactions0
No derivative transactions reported